Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond

Uveal melanoma (UM) is the most common ocular malignancy in adults, associated with the poorest prognosis, with metastatic disease occurring in up to 50% of patients. In contrast to metastatic cutaneous melanoma, the use of immune checkpoint inhibitors is associated with poor outcomes in metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerard, C., Shum, B., Nathan, P., Turajlic, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362360/
https://www.ncbi.nlm.nih.gov/pubmed/37483658
http://dx.doi.org/10.1016/j.iotech.2023.100386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362360/
https://www.ncbi.nlm.nih.gov/pubmed/37483658
http://dx.doi.org/10.1016/j.iotech.2023.100386

Ejemplares similares